Exponent (NASDAQ:EXPO) Releases Quarterly Earnings Results, Beats Estimates By $0.13 EPS

Exponent (NASDAQ:EXPO) announced its quarterly earnings results on Thursday. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.13, Briefing.com reports. Exponent had a net margin of 18.69% and a return on equity of 28.49%. The company had revenue of $137.21 million for the quarter, compared to analysts’ expectations of $125.98 million. During the same quarter in the previous year, the company earned $0.56 earnings per share. Exponent’s quarterly revenue was up 6.6% on a year-over-year basis.

Exponent Price Performance

Exponent stock traded up $18.66 during midday trading on Friday, reaching $98.34. 552,166 shares of the company traded hands, compared to its average volume of 306,798. The firm has a market capitalization of $4.98 billion, a price-to-earnings ratio of 49.94 and a beta of 0.68. The business has a 50 day moving average of $79.55 and a two-hundred day moving average of $81.92. Exponent has a 12 month low of $64.61 and a 12 month high of $102.72.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, March 8th were paid a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.14%. The ex-dividend date was Thursday, March 7th. This is an increase from Exponent’s previous quarterly dividend of $0.26. Exponent’s dividend payout ratio is currently 57.44%.

Insider Activity at Exponent

In related news, insider Eric Guyer sold 3,367 shares of the stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 2.20% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

EXPO has been the topic of a number of recent research reports. Truist Financial cut their price objective on shares of Exponent from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Friday, February 2nd. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.